
Piramal Pharma Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024".
Filed with NSE · · 21 pages · English
Piramal Pharma Limited has announced its consolidated results for the first quarter of the financial year, highlighting significant growth in revenue and EBITDA compared to the previous year. The results presentation includes insights into the company's various business segments, including consumer healthcare and hospital generics, which have shown robust demand and growth.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Piramal Pharma Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024".
Follow Piramal Pharma into a list and get an email when it puts out news.
Follow Piramal Pharma